Experience of successful use of immunotherapy in treatment of locally advanced inoperable squamous cell carcinoma of the hairy part of the head
https://doi.org/10.17650/2782-3202-2023-3-1-48-52
Abstract
This article presents the experience of successful use of immunotherapy in treatment of locally advanced inoperable squamous cell carcinoma of the hairy part of the head.
About the Authors
B. G. Pkheshkhova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; Рeoples’ Friendship University of Russia (RUDN University)
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
6 Miklukho-Maklaya St., Moscow 117198
A. M. Mudunov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Bld. 2, 8 Trubetskaya St., Moscow 119991
M. B. Pak
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Bld. 2, 8 Trubetskaya St., Moscow 119991
P. A. Zeynalova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Bld. 2, 8 Trubetskaya St., Moscow 119991
A. F. Batsev
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Russian Federation
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
References
1. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 252 с. Malignant neoplasms in Russia in 2021 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 252 p. (In Russ.).
2. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166(5):1069–80. DOI: 10.1111/j.1365-2133.2012.10830.x
3. Brougham N.D., Dennett E.R., Cameron R., Tan S.T. The incidence of metastasis form cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012;106(7):811–5. DOI: 10.1002/jso.23155
4. Benjamin C.L., Ananthaswamy H.N. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2007;224(3):241–8. DOI: 10.1016/j.taap.2006.12.006
5. Liu Q., Yu S., Zhao W. et al. EGFR-TKIs resistance via EGFR-independent signaling pathways. Mol Cancer 2018;17(1):53. DOI: 10.1186/s12943-018-0793-1
6. Hung K.F., Sidorova J.M., Nghiem P., Kawasumi M. The 6–4 photoproduct is the trigger of UV-induced replication blockage and ATR activation. Proc Natl Acad Sci U S A 2020;117(23):12806–16. DOI: 10.1073/pnas.1917196117
7. Pickering C.R., Zhou J.H., Lee J.J. et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 2014;20(24):6582–92. DOI: 10.1158/1078-0432.CCR-14-1768
8. Potenza C., Bernardini N., Balduzzi V. et al. A review of the literature of surgical and nonsurgical treatments of invasive squamous cells carcinoma. Biomed Res Int 2018;2018:9489163. DOI: 10.1155/2018/9489163
9. Sapijaszko M., Zloty D., Bourcier M. et al. Non-melanoma skin cancer in Canada. Chapter 5: Management of squamous cell carcinoma. J Cutan Med Surg 2015;19(3):249–59. DOI: 10.1177/1203475415582318
10. Veness M.J., Morgan G.J., Palme C.E., Gebski V. Surgery and adjuvant radiоtherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005;115(5):870–5. DOI: 10.1097/01.MLG.0000158349.64337.ED
11. Karia P.S., Morgan F.C., Ruiz E.S., Schmults C.D. Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: a systematic review and Pooled Analysis of Outcomes Data. JAMA Dermatol 2017;153(8):781–8. DOI: 10.1001/jamadermatol.2017.1680
12. Cognetta A.B., Howard B.M., Heaton H.P. et al. Superficial x-ray in the treatment of basal and squamous cell carcinomas: A viable option in select patients. J Am Acad Dermatol 2012;67(6):1235–41. DOI: 10.1016/j.jaad.2012.06.001
13. Schmults C.D., Blitzblau R., Aasi S.Z. et al. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. J Natl Compr Canc Netw 2021;19(12):1382–94. DOI: 10.6004/jnccn.2021.0059
14. Peyrade F., Kogay M., Viotti J. et al. Cetuximab in patients with unresectable cutaneous squamous cell carcinoma is safe and effective: a real-life analysis. Ann Oncol 2018;29(Suppl 8):viii442–viii466. DOI: 10.1093/ANNONC/MDY289.049
15. Foote M.C., McGrath M., Guminski A. et al. Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. Ann Oncol 2014;25(10):2047–52. DOI: 10.1093/annonc/mdu368
16. Maubec E., Boubaya M., Petrow P. et al. Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN. J Clin Oncol 2019;37(15 Suppl):9547. DOI: 10.1200/JCO.2019.37.15_suppl.9547
17. Blum V., Müller B., Hofer S. et al. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases. Eur J Dermatol 2018;28(1):78–81. DOI: 10.1684/ejd.2017.3209
18. Borradori L., Sutton B., Shayesteh P., Daniels G.A. Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases. Br J Dermatol 2016;175(6):1382–6. DOI: 10.1111/bjd.14642
Review
For citations:
Pkheshkhova B.G., Mudunov A.M., Pak M.B., Zeynalova P.A., Batsev A.F. Experience of successful use of immunotherapy in treatment of locally advanced inoperable squamous cell carcinoma of the hairy part of the head. MD-Onco. 2023;3(1):48-52. (In Russ.) https://doi.org/10.17650/2782-3202-2023-3-1-48-52
Views:
312
Email this article 